Perceptive Capital Solutions Corp (PCSC)
| Market Cap | 121.52M +8.9% |
| Revenue (ttm) | n/a |
| Net Income | 107,164 |
| EPS | 0.01 |
| Shares Out | 11.07M |
| PE Ratio | 1,133.97 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 461,406 |
| Open | 10.60 |
| Previous Close | 10.80 |
| Day's Range | 9.95 - 11.10 |
| 52-Week Range | 9.95 - 14.47 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About PCSC
Perceptive Capital Solutions Corp does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities operating in the life sciences and medical technology sectors in North America or Europe. Perceptive Capital Solutions Corp was incorporated in 2024 and is based in New York, New York.
News
Perceptive Capital Solutions Corp Announces Change of Date of Extraordinary General Meeting of Shareholders
– Extraordinary General Meeting of Perceptive Shareholders Postponed to July 15, 2026 NEW YORK, July 9, 2026 /PRNewswire/ -- Perceptive Capital Solutions Corp ("PCSC") (Nasdaq: PCSC), a special purpos...
Perceptive Capital, Freenome announce registration statement for combination
Perceptive Capital (PCSC), a special purpose acquisition company sponsored by an affiliate of Perceptive Advisors, and Freenome Holdings, an early cancer detection company developing blood-based scree...
Freenome, Perceptive Capital Solutions announce business combination agreement
Freenome Holdings and Perceptive Capital Solutions (PCSC), announced that they have entered into a definitive business combination agreement. Upon closing of the transaction, PCSC will redomicile as a...